High-Risk Drug Monitoring · Shrewsbury, West Midlands

High-Risk Drug Monitoring in Shrewsbury.

A complete pharmacist-led high-risk drug monitoring service — DMARDs, lithium, amiodarone, anticoagulants and shared-care drugs — with cohort identification, recall, monitoring blood tests, prescriber review and audit-ready coding. The clinical risk that keeps GPs awake at night, taken off the practice. For Shrewsbury PCNs, mobilisation runs from our Halifax (West Yorkshire) hub.

High-Risk Drug Monitoring for Shrewsbury PCNs and GP practices.

Bespoke Clinical Services delivers high-risk drug monitoring to Primary Care Networks and GP practices in Shrewsbury and across West Midlands. Every placement in Shrewsbury is governed by the same compliance stack we run nationally — Cyber Essentials, NHS DSPT, GPhC-registered pharmacists, full clinical indemnity and DPIA documentation per contract. The Shrewsbury service is mobilised from our Halifax (West Yorkshire) hub.

PCN Clinical Directors and Practice Managers in Shrewsbury get a single SLA, a single monthly outcomes report and a single escalation point — the BCS managed model, applied to high-risk drug monitoring specifically.

What we deliver

What high-risk drug monitoring in Shrewsbury actually looks like.

  • Cohort identification for DMARDs, lithium, amiodarone, anticoagulants
  • Shared-care drug recall and monitoring scheduling
  • Pharmacist-led blood test interpretation and dose adjustment
  • Patient-facing safety counselling for high-risk medicines
  • Coding against NICE and BNF monitoring requirements
  • Monthly safety dashboard per practice

Why BCS

Why Shrewsbury PCNs choose BCS for high-risk drug monitoring.

Solo recruitment for high-risk drug monitoring in Shrewsbury leaves a PCN exposed to sickness, maternity and retention risk, and rarely meets the supervision standard required for ARRS audit. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, cover is guaranteed and outcomes are evidenced every month.

  • Weekly clinical supervision from a senior pharmacist at the Halifax (West Yorkshire) hub
  • Same-week sickness, leave and maternity cover — no service gap in Shrewsbury
  • Mobilisation in 4–6 weeks, not 4–6 months
  • Outcomes reported against PCN DES 2026/27, IIF and QOF
  • One SLA, one report, one escalation point for the Shrewsbury clinical director

Shrewsbury · what good looks like

Typical first-year outcomes.

4–6 wks
Mobilisation for a Shrewsbury PCN
100%
Supervision evidenced for ARRS audit
Monthly
QA-checked outcomes report
1 SLA
One contract, one report, one escalation

Outcomes

Measurable outcomes — every month.

  • Reduction in overdue monitoring on high-risk drugs
  • Defensible CQC-ready safety audit trail
  • Lower indemnity exposure for the practice
  • GP and partner time released from monitoring admin

Shrewsbury in context — West Midlands.

PCNs in Shrewsbury sit within the wider West Midlands health economy and share its pressures: growing polypharmacy in older adults, rising care home demand, ICB cost-pressure on the prescribing budget, and the operational challenge of converting ARRS allocation into measurable patient outcomes. BCS works alongside Clinical Directors, Practice Managers and ICB Medicines Optimisation teams across West Midlandsto turn pharmacist capacity into measurable change.

Whether you are a single PCN in Shrewsbury planning your first high-risk drug monitoring placement, or a federation co-ordinating cover across multiple West Midlands networks, BCS scales to fit.

Frequently asked questions — High-Risk Drug Monitoring in Shrewsbury.

Which drugs does the service cover?+

DMARDs, lithium, amiodarone, anticoagulants (including DOACs and warfarin) and the most commonly shared-care drugs. The full list is agreed with the PCN at mobilisation.

Do you action results or just flag them?+

Action. Our independent prescribers adjust doses, manage interactions and arrange repeat monitoring within agreed protocols. We escalate only the genuine clinical decisions.

How is this evidenced for CQC?+

Every action is coded against the relevant SNOMED codes and rolled up into a monthly safety pack. It is designed to be CQC-inspection-ready out of the box.

Does BCS already deliver high-risk drug monitoring in Shrewsbury?+

BCS supports PCNs and GP practices across West Midlands from our Halifax (West Yorkshire) hub, and is actively delivering or available to mobilise high-risk drug monitoring in Shrewsbury. Get in touch and we'll confirm current capacity for your network specifically.

How quickly can BCS mobilise high-risk drug monitoring in Shrewsbury?+

In most cases BCS mobilises high-risk drug monitoring for a Shrewsbury PCN within 4 to 6 weeks of contract sign-off, with remote prescribing back-up available from the Halifax (West Yorkshire) hub sooner if needed.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call